Vandetanib (VAN) in locally advance or metastatic medullary thyroid cancer (MTC): A randomized, double-blind phase III trial (ZETA) Meeting Abstract
| Authors: | Wells, S. A.; Robinson, B. G.; Gagel, R. F.; Dralle, H.; Fagin, J. A.; Santoro, M.; Baudin, E.; Vasselli, J. R.; Read, J.; Schlumberger, M. |
| Abstract Title: | Vandetanib (VAN) in locally advance or metastatic medullary thyroid cancer (MTC): A randomized, double-blind phase III trial (ZETA) |
| Meeting Title: | 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 28 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2010 Jun 4-8 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2010-05-20 |
| Start Page: | 421s |
| Language: | English |
| ACCESSION: | WOS:000208852004182 |
| DOI: | 10.1200/jco.2010.28.15_suppl.5503 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 5503 -- Source: Wos |
